Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG.

OBJECTIVE To investigate the release of interferon-alpha (IFN alpha)-inducing material by necrotic or apoptotic cells, its properties, and the necessity of autoantibodies from systemic lupus erythematosus (SLE) patients for the interferogenic activity. METHODS U937 monocytic leukemia cells or peripheral blood mononuclear cells (PBMCs) were rendered necrotic by freeze-thawing or apoptotic by treatment with ultraviolet light. Cell culture supernatants from these cells and IgG from SLE patients (SLE IgG) were added to cultures of normal PBMCs or purified plasmacytoid dendritic cells (PDCs). The importance of nucleic acids for IFN alpha induction was investigated by RNase and DNase treatment. The IFN alpha levels were measured by immunoassay. RESULTS Both necrotic and apoptotic U937 cells released material that, combined with SLE IgG, induced IFN alpha production in PDCs. The release from apoptotic cells occurred with a 16-hour delay, in late apoptosis. Also, normal PBMCs released IFN alpha-inducing material, but only during necrosis. The interferogenic activity of the necrotic material required the presence of RNA, while both RNA and DNA were important in the apoptotic material. In both cases, the presence of SLE IgG was necessary, and its activity correlated with the presence of antibodies to RNA-binding proteins, but not anti-DNA antibodies. CONCLUSION Necrotic and late apoptotic cells release material that, combined with SLE IgG, induces production of IFN alpha in PDCs. The IFN alpha inducers probably consist of immune complexes (ICs) containing RNA and possibly DNA as essential interferogenic components. The presence of such interferogenic ICs could explain the ongoing production of IFN alpha in SLE and could be of etiopathogenic importance.

[1]  E. Chan,et al.  13 – ANTIBODIES TO NONHISTONE ANTIGENS IN SYSTEMIC LUPUS ERYTHEMATOSUS , 2004 .

[2]  L. Rönnblom,et al.  FcγRIIa Is Expressed on Natural IFN-α-Producing Cells (Plasmacytoid Dendritic Cells) and Is Required for the IFN-α Production Induced by Apoptotic Cells Combined with Lupus IgG 1 , 2003, The Journal of Immunology.

[3]  L. Rönnblom,et al.  Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus. , 2003, Arthritis and rheumatism.

[4]  V. Sigurdsson,et al.  Photosensitivity in patients with lupus erythematosus: a clinical and photobiological study of 100 patients using a prolonged phototest protocol , 2003, The British journal of dermatology.

[5]  G. Karypis,et al.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[6]  S. Akira,et al.  Recognition of pathogen-associated molecular patterns by TLR family. , 2003, Immunology letters.

[7]  L. Rönnblom,et al.  The natural interferon-α producing cells in systemic lupus erythematosus , 2002 .

[8]  C. Plass,et al.  Alterations of DNA methylation in hematologic malignancies. , 2002, Cancer letters.

[9]  P. Fitzgerald-Bocarsly.  Natural Interferon-α Producing Cells: The Plasmacytoid Dendritic Cells , 2002 .

[10]  S. Van Cruchten,et al.  Morphological and biochemical aspects of apoptosis, oncosis and necrosis. , 2002 .

[11]  B. Richardson,et al.  Role of DNA methylation in the regulation of cell function: autoimmunity, aging and cancer. , 2002, The Journal of nutrition.

[12]  M. Crow,et al.  T Cell Proliferation Induced by Autologous Non-T Cells Is a Response to Apoptotic Cells Processed by Dendritic Cells1 , 2002, The Journal of Immunology.

[13]  L. Klareskog,et al.  Increased T-lymphocyte apoptosis/necrosis and IL-10 producing cells in patients and their spouses in Icelandic systemic lupus erythematosus multicase families , 2002, Lupus.

[14]  R. Vabulas,et al.  Bacterial CpG‐DNA and lipopolysaccharides activate Toll‐like receptors at distinct cellular compartments , 2002, European journal of immunology.

[15]  S. Akira,et al.  Interferon-α and Interleukin-12 Are Induced Differentially by Toll-like Receptor 7 Ligands in Human Blood Dendritic Cell Subsets , 2002, The Journal of experimental medicine.

[16]  T. Giese,et al.  Quantitative Expression of Toll-Like Receptor 1–10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides1 , 2002, The Journal of Immunology.

[17]  P. Matzinger.  The Danger Model: A Renewed Sense of Self , 2002, Science.

[18]  M. Shlomchik,et al.  Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors , 2002, Nature.

[19]  I. Caramalho,et al.  IFN‐α/β enhances BCR‐dependent B cell responses , 2002 .

[20]  P. Raanani,et al.  Immune-Mediated Complications during Interferon Therapy in Hematological Patients , 2002, Acta Haematologica.

[21]  F. Belardelli,et al.  Cytokines as a link between innate and adaptive antitumor immunity. , 2002, Trends in immunology.

[22]  L. Rönnblom,et al.  Importance of CpG Dinucleotides in Activation of Natural IFN‐α‐Producing Cells by a Lupus‐Related Oligodeoxynucleotide , 2001, Scandinavian journal of immunology.

[23]  Y. Shoshan,et al.  Accelerated Fas-Mediated Apoptosis of Monocytes and Maturing Macrophages from Patients with Systemic Lupus Erythematosus: Relevance to In Vitro Impairment of Interaction with iC3b-Opsonized Apoptotic Cells1 , 2001, The Journal of Immunology.

[24]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[25]  L. Rönnblom,et al.  An etiopathogenic role for the type I IFN system in SLE. , 2001, Trends in immunology.

[26]  R. Fujinami.  Viruses and autoimmune disease – two sides of the same coin? , 2001, Trends in Microbiology.

[27]  L. Rönnblom,et al.  Activation of natural interferon-alpha producing cells by apoptotic U937 cells combined with lupus IgG and its regulation by cytokines. , 2001, Journal of autoimmunity.

[28]  V. Hornung,et al.  Identification of CpG oligonucleotide sequences with high induction of IFN‐α/β in plasmacytoid dendritic cells , 2001 .

[29]  L. Rönnblom,et al.  Presence of cutaneous interferon-a producing cells in patients with systemic lupus erythematosus , 2001, Lupus.

[30]  F. Lund-Johansen,et al.  Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. , 2001, The American journal of pathology.

[31]  B. Hallberg,et al.  Interferon-α Promotes Survival of Human Primary B-Lymphocytes via Phosphatidylinositol 3-Kinase , 2001 .

[32]  Amer A. Beg,et al.  An Essential Role of the NF-κB/Toll-Like Receptor Pathway in Induction of Inflammatory and Tissue-Repair Gene Expression by Necrotic Cells1 , 2001, The Journal of Immunology.

[33]  C. Biron.  Interferons α and β as Immune Regulators—A New Look , 2001 .

[34]  W. V. van Venrooij,et al.  Autoimmune response to U1 small nuclear ribonucleoprotein (U1 snRNP) associated with cytomegalovirus infection , 2001, Arthritis research.

[35]  F. Belardelli,et al.  Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. , 2001, Immunity.

[36]  S. Miltenyi,et al.  BDCA-2, BDCA-3, and BDCA-4: Three Markers for Distinct Subsets of Dendritic Cells in Human Peripheral Blood , 2000, The Journal of Immunology.

[37]  N. Brot,et al.  C-Reactive Protein Binds to Apoptotic Cells, Protects the Cells from Assembly of the Terminal Complement Components, and Sustains an Antiinflammatory Innate Immune Response , 2000, The Journal of experimental medicine.

[38]  G. Sturfelt,et al.  Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies , 2000, Lupus.

[39]  D. Kulms,et al.  Molecular mechanisms of UV‐induced apoptosis , 2000, Photodermatology, photoimmunology & photomedicine.

[40]  L. Rönnblom,et al.  The Combination of Apoptotic U937 Cells and Lupus IgG Is a Potent IFN-α Inducer3 , 2000, The Journal of Immunology.

[41]  C. Bogdan.  The function of type I interferons in antimicrobial immunity. , 2000, Current opinion in immunology.

[42]  D. Isenberg,et al.  Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. , 2000, Arthritis and rheumatism.

[43]  J. A. Majde.  Viral double-stranded RNA, cytokines, and the flu. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[44]  Nina Bhardwaj,et al.  Consequences of cell death: exposure to necrotic tumor cells , 2000 .

[45]  D. Pisetsky.  Immune responses to DNA in normal and aberrant immunity , 2000, Immunologic research.

[46]  B. Weill,et al.  FCgammaRII (CD32)-dependent induction of interferon-alpha by serum from patients with lupus erythematosus. , 1999, European cytokine network.

[47]  L. Rönnblom,et al.  Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus. , 1999, Journal of immunology.

[48]  Stefania Gallucci,et al.  Natural adjuvants: Endogenous activators of dendritic cells , 1999, Nature Medicine.

[49]  A. Namane,et al.  Abnormal DNA methylation and deoxycytosine‐deoxyguanine content in nucleosomes from lymphocytes undergoing apoptosis , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  D. Jarrossay,et al.  Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon , 1999, Nature Medicine.

[51]  N. Kadowaki,et al.  The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.

[52]  P. Marrack,et al.  Type I Interferons Keep Activated T Cells Alive , 1999, The Journal of experimental medicine.

[53]  L. Rönnblom,et al.  Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon‐alpha (IFN‐α) production acting on leucocytes resembling immature dendritic cells , 1999, Clinical and experimental immunology.

[54]  L. Rönnblom,et al.  Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells. , 1998, Journal of autoimmunity.

[55]  A. N. Park,et al.  Interferon‐α and granulocyte‐macrophage colony‐stimulating factor differentiate peripheral blood monocytes into potent antigen‐presenting cells , 1998, Journal of leukocyte biology.

[56]  K. Pang,et al.  Type I IFNs enhance the terminal differentiation of dendritic cells. , 1998, Journal of immunology.

[57]  R. Voll,et al.  Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. , 1998, Arthritis and rheumatism.

[58]  P. Fitzgerald-Bocarsly,et al.  Exogenous and endogenous IL-10 regulate IFN-alpha production by peripheral blood mononuclear cells in response to viral stimulation. , 1998, Journal of immunology.

[59]  K. Kälkner,et al.  Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon. , 1998, QJM : monthly journal of the Association of Physicians.

[60]  V. Fadok,et al.  Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. , 1998, The Journal of clinical investigation.

[61]  M. Herrmann,et al.  High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus , 1998, Lupus.

[62]  J. Piette,et al.  Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and absence of clear association with disease activity. , 1997, Arthritis and rheumatism.

[63]  R. Voll,et al.  Immunosuppressive effects of apoptotic cells , 1997, Nature.

[64]  A. Johannisson,et al.  The Cell Surface Phenotype of Human Natural Interferon‐α Producing Cells as Determined by Flow Cytometry , 1996, Scandinavian journal of immunology.

[65]  W. Emlen,et al.  Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. , 1994, Journal of immunology.

[66]  M. Hylkema,et al.  Clinical evaluation of a modified ELISA, using photobiotinylated DNA, for the detection of anti-DNA antibodies. , 1994, Journal of immunological methods.

[67]  D. Isenberg,et al.  Appearance of anti-DNA antibodies in patients treated with interferon-alpha. , 1993, Arthritis and rheumatism.

[68]  L. Rönnblom,et al.  Possible induction of systemic lupus erythematosus by interferon‐α treatment in a patient with a malignant carcinoid tumour , 1990, Journal of internal medicine.

[69]  T. Kirkwood,et al.  The first international standard for antibodies to double stranded DNA. , 1988, Annals of the rheumatic diseases.

[70]  O. Strannegard,et al.  Interferon and natural killer cells in systemic lupus erythematosus. , 1982, Clinical and experimental immunology.

[71]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[72]  R. Friedman,et al.  Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. , 1982, Science.

[73]  T. Schnitzer,et al.  Serum interferon levels in patients with systemic lupus erythematosus. , 1982, Arthritis and rheumatism.